Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 5,849 shares of RARE stock, worth $227,994. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,849
Previous 6,561
10.85%
Holding current value
$227,994
Previous $364,000
32.42%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$218 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$168 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$106 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97.9 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.73B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...